Background: Catheter based renal artery denervation has demonstrated to be effective in decreasing blood pressure among patients with refractory hypertension. The anatomical distribution of renal artery nerves may influence the safety and efficacy profile of this procedure. We aimed to describe the anatomical distribution and density of renal artery nerves in the porcine model. Methods: A total 8 porcine renal arteries were included in the analysis. A tissue block containing the renal arteries and peri-renal tissue was extracted. Each artery was divided into 3 individual segments (proximal, mid and distal) and stained for histological analysis. Histological sections were assessed for total number, size (0-50 m, 50-100m, 100-200 m, 200-500 m) and depth (1 to 6 mm from renal artery) of the nerves according to the location. Immunohistochemistry, targeting tyrosine hydroxylase (efferent nerve fibers [ENF]) and calcitonin gene related peptide (CGRP, afferent nerve fibers [ANF]) was performed in a mid-section. Results: Nerve counts were greatest proximally (57.2% of the total nerves) and decreased gradually distally (23.5%in mid-sections and 19.3% in distal sections). The distribution in nerve size was similar across all three sections (ϳ40% of the nervesϭ 50-100 m, ϳ30% of the nervesϭ 0-50 m, ϳ20% of the nervesϭ 100-200 m and ϳ10% of the nervesϭ 200-500 m). In the proximal segments ϳ33% of the nerves were located within 2-mm from the arterial wall. In the mid (28%) and distal segments (42%) were located within 1-mm from the arterial wall. Sympathetic efferent fibers overwhelmingly outnumbered sensory afferent fibers. The afferent and efferent fibers were frequently intermixed within the nerve bundle. Conclusions: In the porcine model, renal artery nerves are more frequently seen in the proximal segment of the artery. Nerve size distribution appears to be homogeneous throughout the artery length. Nerve bundles progress closer to the arterial wall in the distal segments of the artery. This anatomical distribution may have implications for the future development of renal denervation therapies.
Background: The long term outcome of stent malapposition after stent implantation remains unclear. The aim of this study was to evaluate serial changes of stent malapposition after everolims-eluting stent implantation by using optical coherence tomography (OCT). Methods: Randomized Evaluation of Sirolims-eluting versus Everolims-eluting stent Trial (RESET) was a prospective dual-arm randomized trial of everolims-eluting stents and sirolims-eluting stents in 3200 patients with coronary artery disease. From the RESET trial, 70 patients with everolims-eluting stents who underwent serial OCT examination (post-stenting and 12-month follow-up) were investigated. Results: At post-stenting, acute stent malapposition was observed in 23 (32%) everolimseluting stents, and 115 malapposed stent struts were detected. Mean stent malapposed distance (distance from stent strut to lumen surface) was 210 Ϯ 240 m at post-stenting. At 12-month follow-up, 15 (65%) stent malapposition was resolved, however 8 (35%) stent malapposition was persistent. A total of 41 persistent malapposed stent struts were detected, and mean stent malapposed distance was 110 Ϯ 190 m at 12-month follow-up. The ROC curves showed that stent malapposed distance Ͼ 290m at post-stenting was the best cut-off to predict persistent stent malapposition at 12-month follow-up in everolims-eluting stents.
Conclusions:
The stent with malapposed distance Ͼ 290m at post-stenting has a high risk for persistent stent malapposition at 12-month follow-up in everolims-eluting stents. OCT can predict persistent stent malapposition and provide useful information to optimize percutaneous coronary intervention. 
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